Simplifying Antibody Discovery with Automation - Infographic

Overview

Monoclonal antibodies (mAbs) are highly valued in therapeutic applications for their exceptional capacity to selectively bind diverse targets with strong specificity and affinity. The roster of clinically approved mAbs has seen considerable expansion over the last ten years, with projections indicating continued growth.

Traditional methods for mAb generation, such as single B-cell screening via fluorescence-activated cell sorting (FACS) and hybridoma screening through limiting dilution, face several challenges. Consequently, there is a movement towards adopting automated, image-based technologies that streamline processes, reduce expenses, and support compliance standards.

• Document type: Infographic
• Page count: 1
• Read time: 3 minutes

Complete the Form to Access the Infographic